In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
GoodRx Holdings Inc (NASDAQ: GDRX) closed the day trading at $4.26 down -9.17% from the previous closing price of $4.69. In other words, the price has decreased by -$9.17 from its previous closing price. On the day, 4.34 million shares were traded.
Ratios:
For a better understanding of GDRX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.95. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.32. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Neutral rating and assigned the stock a target price of $5.
On August 09, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $10.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on May 23, 2024, whereas the target price for the stock was revised from $8 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Bradley Julie MB bought 95,255 shares for $4.95 per share.
Spectrum Equity VII, L.P. sold 10,677 shares of GDRX for $83,922 on Sep 03 ’24. The 10% Owner now owns 0 shares after completing the transaction at $7.86 per share. On Sep 03 ’24, another insider, Spectrum VII Investment Manage, who serves as the Affiliate of the company, bought 6,828 shares for $7.86 each.
Valuation Measures:
As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 100.00, and their Forward P/E ratio for the next fiscal year is 8.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.06 while its Price-to-Book (P/B) ratio in mrq is 2.25.
Stock Price History:
Over the past 52 weeks, GDRX has reached a high of $9.26, while it has fallen to a 52-week low of $3.82. The 50-Day Moving Average of the stock is -6.59%, while the 200-Day Moving Average is calculated to be -25.50%.
Shares Statistics:
A total of 105.95M shares are outstanding, with a floating share count of 88.88M. Insiders hold about 76.83% of the company’s shares, while institutions hold 16.09% stake in the company.
